Clinical Trial Update: Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START) [Phase 3]

View source ↗

Summary

A Phase 3 trial (START) evaluating the belagenpumatucel-L cancer vaccine in unresectable stage III non-small cell lung cancer has completed. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• belagenpumatucel-L (belagenpumatucel-L)

Snippet

Sponsor: EMD Serono | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-11-20